Psychosis Clinical Trial
Official title:
Connection to Environment With Cognitive Therapy (CONNECT): Exploring Trauma, Voices and Dissociation Through Targeted Psychological Intervention. A Single-Case Experimental Design
Connection to Environment with Cognitive Therapy (CONNECT): A Single-Case Experimental Design
Exploring Dissociative Experiences and Voices
Emerging empirical evidence has suggested that dissociation is a robust determinant of
voice-hearing in psychosis, and that dissociation mediates the link between trauma and
voices. Despite the emerging evidence-base, targeted therapeutic interventions focusing on
dissociation remain largely untested.
The aim of the current study is to investigate whether targeting dissociation leads to
improvements in distressing voices in people with a history of trauma. This will be done by
delivering an eight session intervention called 'CONNECT' to six individuals within the
Glasgow Psychological Trauma Service (GPTS) who hear voices, have experienced trauma and are
dissociating. The intervention will focus on learning strategies to manage dissociation. It
is hypothesised that reduced levels of dissociation will be associated with reduction in the
frequency and distress associated with hearing voices.
This study will use a randomized multiple baseline single-case experimental design, meaning
that participants will be randomly allocated to a baseline of two, three or four weeks and
then will begin eight weeks of Connection to Environment Cognitive Therapy (CONNECT). As well
as daily measures during baseline and intervention phases, there will be four assessment
points (baseline, pre-intervention, post-intervention and follow-up). The study will take
approximately three months plus follow-up one month after therapy ends. Individual levels of
dissociation and voices will be compared during baseline and intervention periods using
visual analysis and Tau-U.
This study will contribute to the evidence-based for dissociation interventions targeting
distressing voices among this population. It serves to investigate the proposed mechanism in
a clinical population using a therapeutic intervention. It will therefore inform clinicians
of the effectiveness and feasibility of using such strategies in clinical practice and may
have good generalizability to practice.
1. Purpose and Design:
We will use a single case experimental design (SCED). This approach is common in early
stage studies when exploring whether an intervention creates therapeutic change,
typically by applying multiple measures to investigate the constructs of interest. A
SCED also offers advantages for this type of exploratory research over a randomized
controlled trial (RCT), because of the rich detail in the data and reduced research
costs. Also, because individuals are compared against their own baseline scores, a
smaller sample can be recruited and participants do not need to be matched by age,
education or other variables to have a comparable control group, like in a RCT. For a
targeted intervention, like CONNECT, which is predicted to lead to change in voices,
even after therapy has stopped, a multiple- baseline design is the most appropriate form
of SCED. We will randomize participants to baseline periods of either two, three, or
four weeks before the intervention begins. This increases confidence that any
therapeutic change is more likely to be because of the intervention, not just natural
change over time. Equally, if therapeutic change is demonstrated across participants
allocated to different baseline lengths, we can be confident that it is not the length
of the baseline that is responsible for this effect.
Importantly, this study has been carefully designed in close partnership with the GPTS
to ensure that it is in line with routine care. Open and close communication between the
main researcher, the field supervisor and the wider team will be important to manage any
ethical issues that may arise.
2. Aims and Hypotheses The aim of the current study is to investigate whether targeting
dissociation through Connection to Environment Cognitive Therapy (CONNECT) is associated
with improvements in distressing voices in people with a history of trauma. It is
hypothesized that reductions in dissociation will lead to improvements in the frequency
and distress associated with hearing voices.
Primary Hypotheses:
- Dissociation will significantly reduce following CONNECT therapy.
- Voice frequency and distress will significantly reduce following CONNECT therapy.
- Reductions in dissociation will precede reductions in voice frequency and distress
Secondary Hypothesis:
- CONNECT therapy will lead to increased perceived movement towards goals.
3. Plan of Investigation This study aims to investigate the above hypotheses by delivering
a dissociation intervention to individuals who hear voices and have experienced trauma.
The variables of interest will be monitored and compared within-participants between and
within baseline and intervention phases. Follow-up data will be gathered one month after
therapy. The intervention (CONNection to Environment with Cognitive Therapy:'CONNECT')
was developed incorporating: a) interventions from current literature including previous
work from a case-series of cognitive therapy in clients with trauma, dissociative
experiences and distressing voices delivered in Manchester by Dr Varese and colleagues
and b) interventions used in clinical practice in the GPTS. This information was
gathered by means of a survey which was circulated by the researcher to the Glasgow
Psychological Trauma Service (GPTS) staff in February 2019. The above information was
collated to develop an integrated CONNECT manual that the therapist will utilize.
CONNECT will adopt a 'toolbox' approach to learning strategies aimed to reduce
dissociation and choice of strategies will therefore vary between participants, as this
will be led by their individual preferences.
Assessment and engagement (sessions 1-3) Early phases of intervention will focus on
psych-education/normalization of voice-hearing and dissociative phenomena, and
intervention strategies targeting dissociation
Introducing strategies to target dissociative phenomena/processes (sessions 4-7) This
phase of therapy emphasizes training and practice of skills to manage dissociative
responses and increase perceived controllability of dissociation. This will be a
'toolbox' approach and therefore led by participant preference.
Consolidation (session 8) This session directly follows intervention and focuses on
consolidating prior learnings from intervention phase. This should consist of no
additional learning of strategies to target dissociation. The purpose of this phase is
to consider future care. Focus will therefore be on relapse prevention, risk management
and linking in with other services or clinicians where appropriate.
Review appointment There will also be a review appointment directly after CONNECT for
the purpose of deciding future care. The field supervisor from the GPTS, Dr Kirsten
Atherton, will be involved in this decision-making process and may also attend the
appointment.
Follow-up at 1 month There will be one appointment one month after CONNECT to
re-administer measures and gain qualitative feedback of participation in therapy.
4. Recruitment:
Potential participants will come into the study via and following their routine
assessment pathway within the GPTS. The experimental intervention would be regarded as a
'phase 1 intervention' within the service. Individuals experiencing voices and
dissociation would be offered the opportunity to participate in the study.
If interested in taking part, the GPTS clinician will (with the individual's consent)
pass on contact information to the main researcher, who will contact participants to
arrange an information sharing appointment. Here, the study will be discussed in full
with reference to the information sheet and any questions will be answered at this
point. If interested in taking part, a follow-up consent appointment will be made
whereby the participant will sign the consent form and fill in screening questionnaires
to ascertain whether the person is suitable for the study based on the below
inclusion/exclusion criteria.
5. Settings and Equipment:
This study will be carried out during working hours in clinical rooms within the GPTS.
Equipment will include participant information sheets, consent forms, paper copies of
measures, paper, pens and a 'toolkit' consisting of various grounding objects e.g. aroma
oils. A digital voice recorder belonging to the University of Glasgow will be used which
is encrypted and password protected.
6. Procedure:
This study utilises a randomized multiple baseline Single-Case Experimental Design
(SCED) with assessment at four time points (baseline, start of intervention, end of
intervention and follow-up). Randomisation: Participants will be randomised to baseline
periods of two, three or four weeks using a pre-determined simple randomisation method.
Randomisation will be completed using a computer-generated sequence before recruitment
begins. The researcher will be blind to the baseline allocation until the point of
consent and screening, when the researcher will open a sealed envelope to reveal this.
All sessions will be audio recorded using an encrypted digital recorder provided by the
University of Glasgow. Recordings will be used for supervision purposes to ensure the
intervention is of high quality and to assess for content and fidelity of intervention.
Interpreters will be accessed as part of routine practice within the GPTS. The
researcher will endeavor to meet with the interpreter before the information sharing
appointment to ensure minimal impact to the study procedure. The researcher will also
endeavor for participants to have the same interpreter for the duration of the study.
The field supervisor has noted this to be feasible within the GPTS.
7. Data Analysis:
Tau-U analysis will be used to analyse changes in outcome variables between the four
assessment time-points. Tau-U is a non-parametric rank order correlation statistic with
promising application for SCED research. Visual data analyses will be conducted to
analyse changes between and within phases. Visual analysis is routinely used in SCED
research and will be conducted according to established guidelines.
8. Justification of Sample Size:
This study aims to recruit a sample of six participants. As per SCED methodology, the
participants in this study will serve as their own baseline. Guidelines for SCED
research suggest that change ought to occur across a minimum of three participants, with
a minimum of three time points per participant in order to account for
between-participant variance and chance. Previous case series of a similar nature have
included between nine and ten participants however participants in these studies did not
have as much outcome data as the current study. Each participant in this study will have
outcome data for four assessment points, as well as daily and in-session measures during
baseline and intervention phases, thus having above the required three measures per
phase. However, it is acknowledged that small sample size may result in limited
generalizability to wider population. Therefore, demographic information will be taken
into consideration when interpreting the results.
9. Ethical Issues:
This study has undergone ethical review from the West of Scotland Research Ethical
Committee (REC) and received approval (REC Reference: 19/WS/0125).
10. Dissemination:
The results will be submitted as part of the Doctorate in Clinical Psychology and will be
read by staff from the Institute of Health and Wellbeing as well as external examiners. This
work will be published in an academic journal, presented at conferences, and other clinical
forums. As CONNECT is a new therapy, individual case reports may also be written and
published in an academic journal to look at the feasibility and applicability of this therapy
in more depth. Dissemination plans will be discussed with participants who will receive a
summary of the results upon completion.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04929938 -
Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients
|
N/A | |
Recruiting |
NCT05863572 -
Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
|
N/A | |
Completed |
NCT04277585 -
Improving Access to Early Psychosis Coordinated Specialty Care
|
N/A | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Not yet recruiting |
NCT05558332 -
Youth Nominated Support Team
|
N/A | |
Not yet recruiting |
NCT05358457 -
Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Completed |
NCT02895269 -
COllaborative Shared Care to IMprove Psychosis Outcome
|
N/A | |
Recruiting |
NCT02622048 -
Understanding and Helping Families: Parents With Psychosis
|
N/A | |
Completed |
NCT02653729 -
Cbt for Psychosis and Affect on Psychosis Symptoms
|
Phase 2 | |
Completed |
NCT02733575 -
Compassion Focused Therapy for Distressing Experiences
|
N/A | |
Completed |
NCT02531243 -
Computer-Aided Learning for Managing Stress
|
N/A | |
Not yet recruiting |
NCT02244970 -
Mindfulness RCT for Early Psychosis
|
N/A | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Recruiting |
NCT00722163 -
A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis
|
Phase 0 |